Monday, February 26, 2007

BiPar Sciences Finds $35M

Brisbane-based BiPar Sciences announced Monday that it has raised $35M in a Series B funding. The round was led by Domain Associates. Existing investors Vulcan Capital, Canaan Partners, PolyTechnos Venture-Partners, Asset Management Company and Quantum Technology Partners also participated in the round. BiPar is developing compounds that are targeted at inhibiting tumors and for new cancer therapies. More information »